Pharmacogenetics
Saturday, 13 April 2002
Organizers:
W. Kirch (Dresden, Germany)
U.I. Schwarz (Dresden, Germany)
Gene polymorphisms in drug therapy |
|||
Session I | |||
Chairs | R.B. Kim (Nashville, USA) W. Kirch (Dresden, Germany) |
||
9.30 – 10.00 | Drug transporter Polymorphisms: An Overview R.B. Kim (Nashville, USA) |
||
10.00 – 10.30 | Impact of MDR-1 polymorphisms on drug disposition M.F. Fromm (Stuttgart, Germany) |
||
10.30 – 11.00 | Grapefruit-juice & drug transport G.K. Dresser (London, Canada) |
||
11.00 – 11.20 | coffee break | ||
11.20 – 11.50 | CYP2D6 polymorphisms I. Cascorbi (Greifswald, Germany) |
||
11.50 – 12.20 | CYP2C9 polymorphisms – implication for drug therapy U.I. Schwarz (Dresden, Germany) |
||
12.20 – 12.30 | discussion, final remarks | ||
12.30 | end of workshop 1 |